Speaker Profile
PMWC LUMINARY AWARD
Advanced geroscience from aging biology to healthy longevity medicine
M.D., Director, NUS Academy for Healthy Longevity, National U. of Singapore
Biography
Andrea Maier is a leading figure in geroscience and healthy longevity medicine, termed precision geromedicine. Her work focuses on translating the biology of ageing into clinical practice to extend healthspan rather than prolong lifespan. She has led international cohort and intervention studies to understand ageing mechanisms and apply them to prevention and care.
Maier has shaped precision geromedicine as an organized field. She is the Founding President of the Healthy Longevity Medicine Society, Scientific Advisory Board member of the Biomarkers of Aging Consortium, and serves on the Board of the Academy for Health and Lifespan Research, placing her at the center of defining standards and direction for this emerging area.
She also builds the clinical infrastructure needed to move precision geromedicine to implementation, leading the Centre for Healthy Longevity at NUS and founding the NUS Academy for Healthy Longevity, making her a prominent voice connecting ageing biology and clinical medicine.
Talk
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Nir Barzilai, Albert Einstein & Mike Snyder, Stanford
PMWC Award Ceremony
• Alexander (Zan) Fleming, Hevolution Foundation (Pioneer)
• Daniel Drucker, Sinai Health (Pioneer)
• Andrea Maier, NUS Yong Loo Lin School of Medicine (Luminary)
Featured Speakers
• Nir Barzilai, Albert Einstein
• Mike Snyder, Stanford
• Andrea Maier, NUS Yong Loo Lin School of Medicine
• Sara Espinoza, Cedars-Sinai
• Brian Kennedy, Buck Institute
• John Newman, Buck Institute / UCSF
• Marco Quarta, Rubedo Life Sciences
• Maria Dermit, Novo Nordisk
• Alan Shuldiner, Regeneron
• David Furman, Stanford
• Steve Horvath, UCLA
• Daniel Belsky, Columbia
• Ahmed Metwally, Google
• Lee Hood, Phenome Health / ISB
• George Slavich, UCLA
Targeting Aging Biology
What is actually druggable today, and what remains wishful thinking.
From Metabolism to Longevity: GLP-1 and Beyond
Incretins reshaping cardiometabolic prevention and healthy aging.
Which Aging Measures Matter?
Biological-age measures and biomarkers that can change clinical decisions.
Wearables & Digital Biomarkers at Scale
Continuous phenotyping and longitudinal signals in real-world aging.
Clinical Translation
Trials, endpoints, regulation, and the hard road to credible longevity medicine.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
